Home / Expert Opinion / IP Frontiers: What’s on sale? The latest on the patent novelty requirement

IP Frontiers: What’s on sale? The latest on the patent novelty requirement

On Jan. 22, 2019, the Supreme Court provided its decision in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.[1] Despite receiving little publicity outside the patent world, it nonetheless has implications for small businesses. The decision provided clarification to the statutory changes made by the America Invents Act (AIA) to the novelty requirement, specifically the ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*